VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$14.48
+0.91 (+6.71%)
As of Mar 29, 10:31 PM ET ·
Financial Highlights (FY 2025)
Revenue
29.07M
Net Income
5.84M
Gross Margin
44.3%
Profit Margin
20.1%
Rev Growth
+18.1%
D/E Ratio
0.64
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 44.3% 44.3% 44.3%
Operating Margin 25.3% 21.8% 23.4%
Profit Margin 20.1% 16.9% 19.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 29.07M 27.10M 30.53M
Gross Profit 12.87M 12.00M 13.52M
Operating Income 7.36M 5.89M 7.14M
Net Income 5.84M 4.59M 6.02M
Gross Margin 44.3% 44.3% 44.3%
Operating Margin 25.3% 21.8% 23.4%
Profit Margin 20.1% 16.9% 19.7%
Rev Growth +18.1% +12.4% +4.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 92.40M 104.31M 115.91M
Total Equity 143.94M 152.98M 165.14M
D/E Ratio 0.64 0.68 0.70
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.15M 7.65M 7.71M
Free Cash Flow 6.21M 7.09M 6.33M